Hosein Azimian
Overview
Explore the profile of Hosein Azimian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bahreyni-Toossi M, Dayyani M, Mahmoudi M, Azimian H
Iran J Basic Med Sci
. 2022 Oct;
25(9):1104-1109.
PMID: 36246068
Objectives: To enhance the efficiency of radiotherapy (RT), implementation of individual-based treatment is essential. In this way, determining individual intrinsic radiosensitivity (IRS) can be useful to achieve minimal adverse effects...
12.
Farhadi S, Bahreyni-Toossi M, Zafari-Ghadim N, Khademi S, Sadat-Darbandi M, Azimian H
Mutat Res Genet Toxicol Environ Mutagen
. 2022 Aug;
881:503528.
PMID: 36031334
The adaptive response (AR), which can be induced by low-dose ionizing radiation (LD), may influence the therapeutic ratio of cancer treatment. We investigated the AR and the DNA double-strand break...
13.
Khademi S, Shakeri-Zadeh A, Solgi R, Azimian H, Ghadiri H
IET Nanobiotechnol
. 2021 Oct;
15(7):594-601.
PMID: 34695296
This study was performed to specify the efficiency of imaging nanoparticle concentration as contrast media in dual-energy computed tomography (DECT). Gold nanoparticles (AuNPs) and gold nanoparticles-conjugated folic acid through cysteamine...
14.
Bahreyni-Toossi M, Azimian H, Aghaee-Bakhtiari S, Mahmoudi M, Sadat-Darbandi M, Zafari N
Mutat Res
. 2021 Aug;
823:111760.
PMID: 34390933
Purpose: Radiotherapy plays a pivotal role in the treatment of cancer. One of the main challenges in this treatment modality is radiation-induced complications in some patients affected by high radiosensitivity...
15.
Bahreyni-Toossi M, Sankian M, Azimian H, Najafi-Amiri M, Khademi S, Abdollahi-Dehkordi S, et al.
J Cancer Res Ther
. 2021 Jun;
17(2):537-542.
PMID: 34121704
Introduction: In the present study, the radioadaptive role of the immune system induced by low dose (LD) was investigated for its in vivo protective activity. Materials And Methods: Quantitative analysis...
16.
Toossi M, Azimian H, Soleymanifard S, Vosoughi H, Dolat E, Rezaei A, et al.
J Cancer Res Ther
. 2020 Dec;
16(Supplement):S68-S73.
PMID: 33380655
Introduction: Radiation-induced bystander effects (RIBE) is the radiobiological effects detected in nonirradiated cells that have received signals from neighboring irradiated cells. In some studies, there are observations that RIBE unexpectedly...
17.
Tohidi F, Sadr-Nabavi A, Haghir H, Fardid R, Rafatpanah H, Azimian H, et al.
Electromagn Biol Med
. 2020 Oct;
40(1):131-137.
PMID: 33081559
The aim of the present study was the investigation of the effects of mobile phones at different daily exposure times on the hippocampal expression of two apoptotic genes. Forty-eight male...
18.
Bahreyni-Toossi M, Zafari N, Azimian H, Mehrad-Majd H, Farhadi J, Nezamdoust F
Cancer Biother Radiopharm
. 2020 Aug;
38(8):506-511.
PMID: 32833505
Radiotherapy is a crucial component of treatment for ∼70% of all cancer patients. The identification of effective biomarkers of radiosensitivity (RS) is a fundamental goal of radiobiology. The authors hypothesize...
19.
Vosoughi H, Azimian H, Khademi S, Rezaei A, Najafi-Amiri M, Vaziri-Nezamdoost F, et al.
Iran J Basic Med Sci
. 2020 Jun;
23(4):449-453.
PMID: 32489559
Objectives: Nowadays, ionizing radiation (IR) has a significant contribution to the diagnostic and therapeutic medicine, and following that, health risks to individuals through unexpected exposure is greatly increased. Therefore, biological...
20.
Khademi S, Sarkar S, Shakeri-Zadeh A, Attaran N, Kharrazi S, Ay M, et al.
Int J Biochem Cell Biol
. 2020 Jan;
120:105695.
PMID: 31982287
No abstract available.